{"gene":"ATP6V0A2","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":2007,"finding":"Loss-of-function mutations in ATP6V0A2, encoding the a2 subunit of the V-type H+ ATPase, cause autosomal recessive cutis laxa type II (ARCL2) and wrinkly skin syndrome, and result in abnormal N- and O-glycosylation of serum proteins (CDG-II) and impaired Golgi trafficking in patient fibroblasts, establishing that the a2 subunit has an essential role in Golgi function.","method":"Patient mutation sequencing, glycosylation analysis of serum proteins, fibroblast trafficking assays","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (genetics, glycomics, cell biology) in a landmark founding paper, widely replicated","pmids":["18157129"],"is_preprint":false},{"year":2006,"finding":"The a2-isoform of V-ATPase localizes specifically to early endosomes and interacts directly with the Arf GEF ARNO in an intra-endosomal acidification-dependent manner; disruption of this interaction reversibly inhibits endocytosis and blocks protein trafficking between early and late endosomes, identifying the a2 subunit as a pH-sensing scaffold that recruits ARNO/Arf6 to regulate the endocytic degradative pathway.","method":"Co-immunoprecipitation, subcellular fractionation, dominant-negative constructs, pharmacological inhibition of V-ATPase acidification, endocytosis assays","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP plus functional rescue and pharmacological dissection in a single rigorous study","pmids":["16415858"],"is_preprint":false},{"year":2009,"finding":"Loss of ATP6V0A2 function (by siRNA knockdown or in ARCL2 patient cells) causes distended Golgi cisternae, accumulation of abnormal lysosomes and multivesicular bodies, accumulation of tropoelastin (TE) in the Golgi and in large intracellular/extracellular aggregates, impaired secretion and intracellular retention of TE, reduced extracellular deposition of mature elastin, and increased apoptosis of elastogenic cells; fibrillin-1 assembly and lysyl oxidase activity are unaffected, placing ATP6V0A2 specifically in the vesicular trafficking and TE secretion pathway.","method":"siRNA knockdown, pulse-chase secretion assays, insoluble elastin assays, immunostaining, TUNEL apoptosis assay, electron microscopy of Golgi/lysosome ultrastructure, nonsense-mediated decay analysis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods establishing mechanistic pathway placement, strong phenotypic specificity controls","pmids":["19321599"],"is_preprint":false},{"year":2012,"finding":"ATP6V0A2 protein localizes to the Golgi apparatus, is absent or reduced in patient dermal fibroblasts carrying loss-of-function mutations, and its deficiency causes a delay in brefeldin A-induced Golgi collapse not seen in cells deficient for other ARCL-associated proteins (GORAB or PYCR1), indicating a specific role for ATP6V0A2 in Golgi membrane dynamics; patient fibroblasts also show elevated TGF-β signaling and increased secreted TGF-β1, implicating ATP6V0A2 in trafficking/signaling crosstalk.","method":"Immunostaining for Golgi localization, Western blot of patient fibroblasts, brefeldin A Golgi collapse assay, TGF-β ELISA and signaling pathway analysis, novel mutation identification by sequencing","journal":"Human genetics","confidence":"High","confidence_rationale":"Tier 2 — direct localization experiment with functional consequence, parallel comparator cell lines, multiple orthogonal readouts","pmids":["22773132"],"is_preprint":false},{"year":2020,"finding":"Cryo-EM structures of the human V-ATPase at up to 2.9 Å resolution in three rotational states reveal that the Vo membrane complex contains the a-subunit isoforms (including a2); ATP6AP1 functions as a structural hub connecting multiple Vo subunits and phospholipids in the c-ring, and a luminal glycan coat formed by glycolipids and glycosylated Vo subunits (which include the a2 subunit) is critical for V-ATPase folding, localization, and stability.","method":"Cryo-electron microscopy, mass spectrometry-assisted model building, identification of glycolipids and phospholipids","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 — high-resolution cryo-EM structure with MS validation, multiple rotational states","pmids":["33065002"],"is_preprint":false}],"current_model":"ATP6V0A2 encodes the a2 subunit of the vesicular H+-ATPase (V-ATPase), which localizes to the Golgi apparatus and early endosomes where it drives organelle acidification; at the Golgi it is required for proper vesicular trafficking, glycoprotein processing (N- and O-glycosylation), and tropoelastin secretion, while at early endosomes it acts as a pH-sensitive scaffold that recruits the Arf GEF ARNO and Arf6 to regulate the endocytic degradative pathway — loss-of-function mutations cause autosomal recessive cutis laxa type II with Golgi fragmentation, impaired elastin secretion, CDG-type glycosylation defects, elevated TGF-β signaling, and increased apoptosis."},"narrative":{"teleology":[{"year":2006,"claim":"Identification of the a2 isoform as a pH-sensitive scaffold on early endosomes resolved how V-ATPase acidification is coupled to vesicular coat recruitment: a2 directly binds the Arf GEF ARNO in an acidification-dependent manner, and disruption of this interaction blocks trafficking from early to late endosomes.","evidence":"Reciprocal co-immunoprecipitation, dominant-negative constructs, pharmacological V-ATPase inhibition, and endocytosis assays in mammalian cells","pmids":["16415858"],"confidence":"High","gaps":["Structural basis of the pH-dependent a2–ARNO interaction is unknown","Whether a2 scaffolding function is independent of its proton-translocating role has not been dissected","Contribution of other a-subunit isoforms to endosomal ARNO recruitment was not tested"]},{"year":2007,"claim":"Human genetics established that a2 is essential for Golgi-based glycoprotein processing: loss-of-function ATP6V0A2 mutations cause ARCL2/wrinkly skin syndrome with CDG-II-type glycosylation defects and impaired Golgi trafficking, linking organelle acidification to a specific Mendelian connective-tissue disorder.","evidence":"Patient mutation sequencing, serum glycoprotein analysis (isoelectric focusing), and fibroblast trafficking assays across multiple affected families","pmids":["18157129"],"confidence":"High","gaps":["Which specific glycosyltransferase steps are pH-sensitive and disrupted by a2 loss was not determined","Genotype–phenotype correlation across different ATP6V0A2 mutations remained incomplete"]},{"year":2009,"claim":"Mechanistic dissection showed that a2 specifically controls tropoelastin secretion and elastin assembly: its loss causes Golgi distension, tropoelastin retention in swollen Golgi cisternae, aberrant lysosomes, reduced extracellular elastin deposition, and increased apoptosis, while fibrillin-1 and lysyl oxidase pathways are unaffected.","evidence":"siRNA knockdown and ARCL2 patient fibroblasts analyzed by pulse-chase secretion assays, insoluble elastin quantification, electron microscopy, and TUNEL apoptosis assay","pmids":["19321599"],"confidence":"High","gaps":["Why tropoelastin is selectively sensitive to a2 loss while other secreted ECM proteins are not is unexplained","Whether apoptosis is a direct consequence of Golgi dysfunction or secondary to aggregated tropoelastin toxicity is unresolved"]},{"year":2012,"claim":"Golgi localization of a2 was directly demonstrated and its role in Golgi membrane dynamics distinguished from other ARCL genes: a2-deficient fibroblasts show delayed brefeldin A-induced Golgi collapse and elevated TGF-β1 secretion, revealing crosstalk between Golgi pH regulation and growth factor signaling.","evidence":"Immunostaining, brefeldin A collapse kinetics, TGF-β ELISA, and comparison with GORAB- and PYCR1-deficient fibroblasts","pmids":["22773132"],"confidence":"High","gaps":["Mechanism by which a2 loss elevates TGF-β signaling (mis-sorting of TGF-β receptors vs. impaired lysosomal degradation) is unresolved","Whether the Golgi-collapse delay reflects altered membrane fusion or fission was not distinguished"]},{"year":2020,"claim":"Cryo-EM structures of the intact human V-ATPase resolved the position of the a-subunit within the Vo membrane sector and revealed that a luminal glycan coat and bound phospholipids are critical for complex assembly, stability, and localization, providing the first atomic-level context for pathogenic ATP6V0A2 mutations.","evidence":"Cryo-EM at up to 2.9 Å resolution in three rotational states with mass spectrometry-assisted identification of glycolipids and phospholipids","pmids":["33065002"],"confidence":"High","gaps":["No isoform-specific structure of the a2 subunit has been determined","How a2-specific sequences determine Golgi/early-endosome targeting versus other a-isoform targeting is structurally unexplained","Impact of specific ARCL2 missense mutations on Vo assembly and rotation has not been modeled"]},{"year":null,"claim":"Key open questions include how a2 isoform-specific sequences determine its dual Golgi/early-endosome targeting, whether a2's scaffolding function for ARNO/Arf6 can be separated from its proton-translocation role, and by what mechanism a2 loss selectively impairs tropoelastin secretion and activates TGF-β signaling.","evidence":"","pmids":[],"confidence":"High","gaps":["No reconstituted system has tested a2 scaffolding independently of proton pumping","Tissue-specific compensation by other a-subunit isoforms is poorly understood","Structural basis for selective tropoelastin retention in a2-null Golgi is unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,1,4]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[1]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[4]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[0,2,3]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[1]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[0,1,2,3]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,1,4]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,2]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0]},{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[2]}],"complexes":["V-ATPase (V0 sector)"],"partners":["ARNO","ARF6","ATP6AP1"],"other_free_text":[]},"mechanistic_narrative":"ATP6V0A2 encodes the a2 isoform of the V0 sector of the vacuolar H+-ATPase, functioning both as a proton-translocation subunit that drives organelle acidification and as a pH-sensitive scaffold that recruits the Arf GEF ARNO and Arf6 to early endosomes to regulate endocytic trafficking between early and late compartments [PMID:16415858]. At the Golgi apparatus, ATP6V0A2 is required for normal cisternae architecture, vesicular trafficking, N- and O-glycoprotein processing, and tropoelastin secretion; its loss causes Golgi distension, intracellular tropoelastin retention, impaired elastin deposition, elevated TGF-β signaling, and increased apoptosis of elastogenic cells [PMID:19321599, PMID:22773132]. High-resolution cryo-EM structures place the a-subunit within the Vo membrane complex, where a luminal glycan coat formed by glycolipids and glycosylated Vo subunits contributes to V-ATPase folding, localization, and stability [PMID:33065002]. Loss-of-function mutations in ATP6V0A2 cause autosomal recessive cutis laxa type II and wrinkly skin syndrome with congenital disorder of glycosylation type II [PMID:18157129]."},"prefetch_data":{"uniprot":{"accession":"Q9Y487","full_name":"V-type proton ATPase 116 kDa subunit a 2","aliases":["Lysosomal H(+)-transporting ATPase V0 subunit a 2","TJ6","Vacuolar proton translocating ATPase 116 kDa subunit a isoform 2"],"length_aa":856,"mass_kda":98.1,"function":"Subunit of the V0 complex of vacuolar(H+)-ATPase (V-ATPase), a multisubunit enzyme composed of a peripheral complex (V1) that hydrolyzes ATP and a membrane integral complex (V0) that translocates protons (By similarity). V-ATPase is responsible for acidifying and maintaining the pH of intracellular compartments and in some cell types, is targeted to the plasma membrane, where it is responsible for acidifying the extracellular environment (By similarity). Essential component of the endosomal pH-sensing machinery (PubMed:16415858). May play a role in maintaining the Golgi functions, such as glycosylation maturation, by controlling the Golgi pH (PubMed:18157129). In aerobic conditions, involved in intracellular iron homeostasis, thus triggering the activity of Fe(2+) prolyl hydroxylase (PHD) enzymes, and leading to HIF1A hydroxylation and subsequent proteasomal degradation (PubMed:28296633)","subcellular_location":"Cell membrane; Endosome membrane","url":"https://www.uniprot.org/uniprotkb/Q9Y487/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ATP6V0A2","classification":"Not Classified","n_dependent_lines":42,"n_total_lines":1208,"dependency_fraction":0.0347682119205298},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000185344","cell_line_id":"CID001642","localizations":[{"compartment":"golgi","grade":3},{"compartment":"er","grade":2}],"interactors":[{"gene":"ATP6AP1","stoichiometry":10.0},{"gene":"ATP6AP2","stoichiometry":10.0},{"gene":"VMA21","stoichiometry":10.0},{"gene":"ATP6V1F","stoichiometry":10.0},{"gene":"ATP6V0D1","stoichiometry":10.0},{"gene":"TMEM199","stoichiometry":10.0},{"gene":"CCDC115","stoichiometry":0.2},{"gene":"ATP6V0C","stoichiometry":0.2},{"gene":"ATP6V1B2","stoichiometry":0.2},{"gene":"CANX","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID001642","total_profiled":1310},"omim":[{"mim_id":"617627","title":"SMALL REGULATORY POLYPEPTIDE OF AMINO ACID RESPONSE; SPAAR","url":"https://www.omim.org/entry/617627"},{"mim_id":"611716","title":"ATPase, H+ TRANSPORTING, LYSOSOMAL, V0 SUBUNIT A2; ATP6V0A2","url":"https://www.omim.org/entry/611716"},{"mim_id":"278250","title":"WRINKLY SKIN SYNDROME; WSS","url":"https://www.omim.org/entry/278250"},{"mim_id":"231070","title":"GERODERMA OSTEODYSPLASTICUM; GO","url":"https://www.omim.org/entry/231070"},{"mim_id":"219200","title":"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A","url":"https://www.omim.org/entry/219200"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Connecting piece","reliability":"Supported"},{"location":"Mid piece","reliability":"Supported"},{"location":"Vesicles","reliability":"Additional"},{"location":"Focal adhesion sites","reliability":"Additional"},{"location":"Principal piece","reliability":"Additional"},{"location":"End piece","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ATP6V0A2"},"hgnc":{"alias_symbol":["TJ6","a2","TJ6s","TJ6M","ATP6a2","J6B7","ATP6N1D","Vph1","Stv1","a2V","RTF"],"prev_symbol":[]},"alphafold":{"accession":"Q9Y487","domains":[{"cath_id":"3.30.70.120","chopping":"2-41_316-370","consensus_level":"medium","plddt":87.1824,"start":2,"end":370},{"cath_id":"3.30.70.2750","chopping":"116-143_171-280","consensus_level":"medium","plddt":84.8246,"start":116,"end":280},{"cath_id":"1.20.58","chopping":"548-678_728-732","consensus_level":"medium","plddt":86.8317,"start":548,"end":732}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y487","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y487-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y487-F1-predicted_aligned_error_v6.png","plddt_mean":81.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ATP6V0A2","jax_strain_url":"https://www.jax.org/strain/search?query=ATP6V0A2"},"sequence":{"accession":"Q9Y487","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y487.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y487/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y487"}},"corpus_meta":[{"pmid":"2600819","id":"PMC_2600819","title":"[3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.","date":"1989","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/2600819","citation_count":572,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10331081","id":"PMC_10331081","title":"Regulation and inhibition of phospholipase A2.","date":"1999","source":"Annual review of pharmacology and toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/10331081","citation_count":487,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8440410","id":"PMC_8440410","title":"New insights on mammalian phospholipase A2(s); comparison of arachidonoyl-selective and -nonselective enzymes.","date":"1993","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/8440410","citation_count":473,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8777586","id":"PMC_8777586","title":"Cytosolic phospholipase A2.","date":"1995","source":"Journal of lipid mediators and cell signalling","url":"https://pubmed.ncbi.nlm.nih.gov/8777586","citation_count":428,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11872155","id":"PMC_11872155","title":"Phospholipase A2.","date":"2002","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11872155","citation_count":420,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9202883","id":"PMC_9202883","title":"Regulatory functions of phospholipase A2.","date":"1997","source":"Critical reviews in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9202883","citation_count":419,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8488570","id":"PMC_8488570","title":"Phospholipase A2 enzymes: regulation and inhibition.","date":"1993","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/8488570","citation_count":268,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23519104","id":"PMC_23519104","title":"Annexin A2 heterotetramer: structure and function.","date":"2013","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/23519104","citation_count":255,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7037640","id":"PMC_7037640","title":"Degradation of immunoglobulins A2, A2, and G by suspected principal periodontal pathogens.","date":"1981","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/7037640","citation_count":212,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9120389","id":"PMC_9120389","title":"Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes.","date":"1997","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9120389","citation_count":208,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1391715","id":"PMC_1391715","title":"Phospholipase A2 and signal transduction.","date":"1992","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/1391715","citation_count":201,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3084897","id":"PMC_3084897","title":"Uteroglobin inhibits phospholipase A2 activity.","date":"1986","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/3084897","citation_count":189,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8252715","id":"PMC_8252715","title":"Serum phospholipases A2 in inflammatory diseases.","date":"1993","source":"Clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8252715","citation_count":183,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15305015","id":"PMC_15305015","title":"Regulatory mechanism and physiological role of cytosolic phospholipase A2.","date":"2004","source":"Biological & pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/15305015","citation_count":176,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2997628","id":"PMC_2997628","title":"Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.","date":"1985","source":"Naunyn-Schmiedeberg's archives of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/2997628","citation_count":168,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14751539","id":"PMC_14751539","title":"Cell signalling through thromboxane A2 receptors.","date":"2004","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/14751539","citation_count":164,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18949548","id":"PMC_18949548","title":"Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2).","date":"2008","source":"Cardiovascular drugs and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/18949548","citation_count":164,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7104328","id":"PMC_7104328","title":"Interaction of phospholipase A2 and phospholipid bilayers.","date":"1982","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/7104328","citation_count":159,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18177747","id":"PMC_18177747","title":"Antibacterial actions of secreted phospholipases A2. Review.","date":"2007","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/18177747","citation_count":152,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10772824","id":"PMC_10772824","title":"The RGG domain in hnRNP A2 affects subcellular localization.","date":"2000","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/10772824","citation_count":151,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15574370","id":"PMC_15574370","title":"S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors.","date":"2005","source":"Frontiers in bioscience : a journal and virtual library","url":"https://pubmed.ncbi.nlm.nih.gov/15574370","citation_count":149,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29115416","id":"PMC_29115416","title":"Annexin A2 and cancer: A systematic review.","date":"2017","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/29115416","citation_count":130,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12531539","id":"PMC_12531539","title":"Phospolipase A2 and apoptosis.","date":"2002","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/12531539","citation_count":123,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12432910","id":"PMC_12432910","title":"Phospholipase A2 receptor: a regulator of biological functions of secretory phospholipase A2.","date":"2002","source":"Prostaglandins & other lipid mediators","url":"https://pubmed.ncbi.nlm.nih.gov/12432910","citation_count":116,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19321599","id":"PMC_19321599","title":"Loss-of-function mutations in ATP6V0A2 impair vesicular trafficking, tropoelastin secretion and cell survival.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19321599","citation_count":111,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9242654","id":"PMC_9242654","title":"Prostaglandin E2 amplifies cytosolic phospholipase A2- and cyclooxygenase-2-dependent delayed prostaglandin E2 generation in mouse osteoblastic cells. Enhancement by secretory phospholipase A2.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9242654","citation_count":109,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15305013","id":"PMC_15305013","title":"Secretory phospholipase A2.","date":"2004","source":"Biological & pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/15305013","citation_count":107,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16880524","id":"PMC_16880524","title":"Lysosomal phospholipase A2 and phospholipidosis.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16880524","citation_count":101,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30125343","id":"PMC_30125343","title":"Annexin A2 (ANX A2): An emerging biomarker and potential therapeutic target for aggressive cancers.","date":"2018","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30125343","citation_count":99,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32575495","id":"PMC_32575495","title":"Annexin A2 in Inflammation and Host Defense.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/32575495","citation_count":99,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8431207","id":"PMC_8431207","title":"Phospholipase A2 and arthritis.","date":"1993","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/8431207","citation_count":96,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11251814","id":"PMC_11251814","title":"Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection.","date":"2001","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/11251814","citation_count":93,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21440088","id":"PMC_21440088","title":"The annexin A2 system and vascular homeostasis.","date":"2011","source":"Vascular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21440088","citation_count":91,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18853244","id":"PMC_18853244","title":"Biology of secretory phospholipase A2.","date":"2008","source":"Cardiovascular drugs and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/18853244","citation_count":89,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28174424","id":"PMC_28174424","title":"Targeting A2 adenosine receptors in cancer.","date":"2017","source":"Immunology and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/28174424","citation_count":89,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29773019","id":"PMC_29773019","title":"Regulatory Functions of Phospholipase A2.","date":"2017","source":"Critical reviews in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29773019","citation_count":88,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14726513","id":"PMC_14726513","title":"Interfacial enzymology of parvovirus phospholipases A2.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14726513","citation_count":88,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9366243","id":"PMC_9366243","title":"Cross-talk between secretory phospholipase A2 and cytosolic phospholipase A2 in rat renal mesangial cells.","date":"1997","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/9366243","citation_count":81,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16443151","id":"PMC_16443151","title":"Role of cytochrome P450 in phospholipase A2- and arachidonic acid-mediated cytotoxicity.","date":"2005","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16443151","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8866672","id":"PMC_8866672","title":"Plasmalogens, phospholipases A2 and signal transduction.","date":"1995","source":"Brain research. Brain research reviews","url":"https://pubmed.ncbi.nlm.nih.gov/8866672","citation_count":77,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9152992","id":"PMC_9152992","title":"Involvement of phospholipase A2 in neurodegeneration.","date":"1997","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/9152992","citation_count":75,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16182442","id":"PMC_16182442","title":"Oncogenic action of phospholipase A2 in prostate cancer.","date":"2005","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/16182442","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14683686","id":"PMC_14683686","title":"Phospholipase A2 isozymes in pregnancy and parturition.","date":"2004","source":"Prostaglandins, leukotrienes, and essential fatty acids","url":"https://pubmed.ncbi.nlm.nih.gov/14683686","citation_count":73,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7925459","id":"PMC_7925459","title":"Structural comparison of phospholipase-A2-binding regions in phospholipase-A2 receptors from various mammals.","date":"1994","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7925459","citation_count":73,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12808451","id":"PMC_12808451","title":"Deletion of cytosolic phospholipase A2 promotes striated muscle growth.","date":"2003","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12808451","citation_count":73,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16775011","id":"PMC_16775011","title":"Heterogeneous nuclear ribonucleoprotein (hnRNP) E1 binds to hnRNP A2 and inhibits translation of A2 response element mRNAs.","date":"2006","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/16775011","citation_count":71,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22855149","id":"PMC_22855149","title":"The association of annexin A2 and cancers.","date":"2012","source":"Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico","url":"https://pubmed.ncbi.nlm.nih.gov/22855149","citation_count":70,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26330668","id":"PMC_26330668","title":"The Biology of Annexin A2: From Vascular Fibrinolysis to Innate Immunity.","date":"2015","source":"Transactions of the American Clinical and Climatological Association","url":"https://pubmed.ncbi.nlm.nih.gov/26330668","citation_count":69,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2510770","id":"PMC_2510770","title":"G protein regulation of phospholipase A2.","date":"1989","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/2510770","citation_count":69,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25760910","id":"PMC_25760910","title":"Association of annexin A2 with cancer development (Review).","date":"2015","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/25760910","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21074554","id":"PMC_21074554","title":"Group XV phospholipase A₂, a lysosomal phospholipase A₂.","date":"2010","source":"Progress in lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/21074554","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2480387","id":"PMC_2480387","title":"Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2.","date":"1989","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/2480387","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22773132","id":"PMC_22773132","title":"Further characterization of ATP6V0A2-related autosomal recessive cutis laxa.","date":"2012","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22773132","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17971878","id":"PMC_17971878","title":"The p11/S100A10 light chain of annexin A2 is dispensable for annexin A2 association to endosomes and functions in endosomal transport.","date":"2007","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/17971878","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6871998","id":"PMC_6871998","title":"Overproduction of bacteriophage Q beta maturation (A2) protein leads to cell lysis.","date":"1983","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/6871998","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9182072","id":"PMC_9182072","title":"Thromboxane A2 and related prostaglandins in airways.","date":"1997","source":"Fundamental & clinical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/9182072","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10905638","id":"PMC_10905638","title":"Phospholipases A2 in ischemic and toxic brain injury.","date":"2000","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/10905638","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11892805","id":"PMC_11892805","title":"The lysis function of RNA bacteriophage Qbeta is mediated by the maturation (A2) protein.","date":"1983","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11892805","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30077006","id":"PMC_30077006","title":"Lysosomal phospholipase A2.","date":"2018","source":"Biochimica et biophysica acta. Molecular and cell biology of lipids","url":"https://pubmed.ncbi.nlm.nih.gov/30077006","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16585943","id":"PMC_16585943","title":"The role of phospholipases A2 in schizophrenia.","date":"2006","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16585943","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2333291","id":"PMC_2333291","title":"HLA-B37 and HLA-A2.1 molecules bind largely nonoverlapping sets of peptides.","date":"1990","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2333291","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10657662","id":"PMC_10657662","title":"Involvement of cytosolic phospholipase A2 and secretory phospholipase A2 in arachidonic acid release from human neutrophils.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10657662","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3097720","id":"PMC_3097720","title":"Interaction of carbamazepine and other drugs with adenosine (A1 and A2) receptors.","date":"1986","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/3097720","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22735340","id":"PMC_22735340","title":"Cyclin A2, Rho GTPases and EMT.","date":"2012","source":"Small GTPases","url":"https://pubmed.ncbi.nlm.nih.gov/22735340","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21455978","id":"PMC_21455978","title":"Secretory phospholipase A₂ responsive liposomes.","date":"2011","source":"Journal of pharmaceutical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/21455978","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27366903","id":"PMC_27366903","title":"The annexin A2 system and angiogenesis.","date":"2016","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27366903","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1465478","id":"PMC_1465478","title":"Membrane structure, toxins and phospholipase A2 activity.","date":"1992","source":"Pharmacology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/1465478","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31738896","id":"PMC_31738896","title":"Preeclampsia: a defect in decidualization is associated with deficiency of Annexin A2.","date":"2019","source":"American journal of obstetrics and gynecology","url":"https://pubmed.ncbi.nlm.nih.gov/31738896","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8131796","id":"PMC_8131796","title":"Cellular activation by thromboxane A2 and other eicosanoids.","date":"1993","source":"European heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/8131796","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30568638","id":"PMC_30568638","title":"Annexin A2 in Virus Infection.","date":"2018","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/30568638","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34202091","id":"PMC_34202091","title":"Annexin A2 in Fibrinolysis, Inflammation and Fibrosis.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34202091","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15354262","id":"PMC_15354262","title":"Platelet receptors for adenine nucleotides and thromboxane A2.","date":"2004","source":"Seminars in thrombosis and hemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/15354262","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22772608","id":"PMC_22772608","title":"Nuclear karyopherin a2: a novel biomarker for infiltrative astrocytomas.","date":"2012","source":"Journal of neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22772608","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2981768","id":"PMC_2981768","title":"Characterization of the HLA-A2.2 subtype: T cell evidence for further heterogeneity.","date":"1985","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/2981768","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15305014","id":"PMC_15305014","title":"Mammalian phospholipase A2: phospholipase A2 receptor.","date":"2004","source":"Biological & pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/15305014","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8138555","id":"PMC_8138555","title":"Distribution of dystrophin isoforms and dystrophin-associated proteins 43DAG (A3a) and 50DAG (A2) in various monkey tissues.","date":"1993","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8138555","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17000881","id":"PMC_17000881","title":"An antiangiogenic neurokinin-B/thromboxane A2 regulatory axis.","date":"2006","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17000881","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2676561","id":"PMC_2676561","title":"Expression and function of HLA-A2.1 in transgenic mice.","date":"1989","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/2676561","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25222280","id":"PMC_25222280","title":"Impaired osteoblast differentiation in annexin A2- and -A5-deficient cells.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25222280","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20501644","id":"PMC_20501644","title":"Crosstalk of EDA-A2/XEDAR in the p53 signaling pathway.","date":"2010","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/20501644","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23226323","id":"PMC_23226323","title":"Genotoxic agents promote the nuclear accumulation of annexin A2: role of annexin A2 in mitigating DNA damage.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23226323","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33714158","id":"PMC_33714158","title":"Mechanisms of Enterobacter bugandensis TJ6 immobilization of heavy metals and inhibition of Cd and Pb uptake by wheat based on metabolomics and proteomics.","date":"2021","source":"Chemosphere","url":"https://pubmed.ncbi.nlm.nih.gov/33714158","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3155656","id":"PMC_3155656","title":"Effects of thromboxane A2 on lymphocyte proliferation.","date":"1985","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/3155656","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17355873","id":"PMC_17355873","title":"Distribution of reaction products in phospholipase A2 hydrolysis.","date":"2006","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/17355873","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12036260","id":"PMC_12036260","title":"Secondary messengers and phospholipase A2 in auxin signal transduction.","date":"2002","source":"Plant molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12036260","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17114477","id":"PMC_17114477","title":"An HLA-A2.1-transgenic rabbit model to study immunity to papillomavirus infection.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17114477","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3994724","id":"PMC_3994724","title":"Immunochemical relatedness between secretory phospholipase A2 and intracellular phospholipase A2.","date":"1985","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/3994724","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32417916","id":"PMC_32417916","title":"Transposon insertions within alleles of BnaFLC.A10 and BnaFLC.A2 are associated with seasonal crop type in rapeseed.","date":"2020","source":"Journal of experimental botany","url":"https://pubmed.ncbi.nlm.nih.gov/32417916","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18566601","id":"PMC_18566601","title":"Cytosolic phospholipase A2 regulates viability of irradiated vascular endothelium.","date":"2008","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/18566601","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7513260","id":"PMC_7513260","title":"Expression of a membrane form of the pregnancy-associated protein TJ6 on lymphocytes.","date":"1994","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7513260","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30216637","id":"PMC_30216637","title":"Targeting the phospholipase A2 receptor ameliorates premature aging phenotypes.","date":"2018","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/30216637","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11830583","id":"PMC_11830583","title":"Identification of a soluble form phospholipase A2 receptor as a circulating endogenous inhibitor for secretory phospholipase A2.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11830583","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8579758","id":"PMC_8579758","title":"Reciprocal alteration in circulating TJ6+ CD19+ and TJ6+ CD56+ leukocytes in early pregnancy predicts success or miscarriage.","date":"1995","source":"American journal of reproductive immunology (New York, N.Y. : 1989)","url":"https://pubmed.ncbi.nlm.nih.gov/8579758","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1990289","id":"PMC_1990289","title":"The core proteins A2 and B1 exist as (A2)3B1 tetramers in 40S nuclear ribonucleoprotein particles.","date":"1991","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/1990289","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9118486","id":"PMC_9118486","title":"Differential desensitization of thromboxane A2 receptor subtypes.","date":"1997","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/9118486","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15451675","id":"PMC_15451675","title":"Crystal structures and electron micrographs of fungal volvatoxin A2.","date":"2004","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15451675","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12350360","id":"PMC_12350360","title":"Expression of the vaccinia virus A2.5L redox protein is required for virion morphogenesis.","date":"2002","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/12350360","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25436557","id":"PMC_25436557","title":"Cyclin A2: a genuine cell cycle regulator?","date":"2012","source":"Biomolecular concepts","url":"https://pubmed.ncbi.nlm.nih.gov/25436557","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16837646","id":"PMC_16837646","title":"Positional specificity of lysosomal phospholipase A2.","date":"2006","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/16837646","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27372915","id":"PMC_27372915","title":"Annexin A2, autoimmunity, anxiety and depression.","date":"2016","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/27372915","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17081983","id":"PMC_17081983","title":"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17081983","citation_count":2861,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11836511","id":"PMC_11836511","title":"The vacuolar (H+)-ATPases--nature's most versatile proton pumps.","date":"2002","source":"Nature reviews. Molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11836511","citation_count":961,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33845483","id":"PMC_33845483","title":"Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/33845483","citation_count":532,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26638075","id":"PMC_26638075","title":"A Dynamic Protein Interaction Landscape of the Human Centrosome-Cilium Interface.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26638075","citation_count":433,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22479202","id":"PMC_22479202","title":"Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals.","date":"2012","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22479202","citation_count":400,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16415858","id":"PMC_16415858","title":"V-ATPase interacts with ARNO and Arf6 in early endosomes and regulates the protein degradative pathway.","date":"2006","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16415858","citation_count":396,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17662945","id":"PMC_17662945","title":"Coupling of rotation and catalysis in F(1)-ATPase revealed by single-molecule imaging and manipulation.","date":"2007","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17662945","citation_count":307,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27342126","id":"PMC_27342126","title":"Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27342126","citation_count":306,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18157129","id":"PMC_18157129","title":"Impaired glycosylation and cutis laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2.","date":"2007","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18157129","citation_count":295,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2874839","id":"PMC_2874839","title":"Receptor-mediated endocytosis: the intracellular journey of transferrin and its receptor.","date":"1986","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/2874839","citation_count":169,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32001091","id":"PMC_32001091","title":"Structure and Roles of V-type ATPases.","date":"2020","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32001091","citation_count":168,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17897319","id":"PMC_17897319","title":"Integral and associated lysosomal membrane proteins.","date":"2007","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/17897319","citation_count":163,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31995728","id":"PMC_31995728","title":"AMPK, a Regulator of Metabolism and Autophagy, Is Activated by Lysosomal Damage via a Novel Galectin-Directed Ubiquitin Signal Transduction System.","date":"2020","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/31995728","citation_count":152,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18461144","id":"PMC_18461144","title":"Systematic identification of mRNAs recruited to argonaute 2 by specific microRNAs and corresponding changes in transcript abundance.","date":"2008","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/18461144","citation_count":148,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19322201","id":"PMC_19322201","title":"Ubiquitin-mediated proteolysis of HuR by heat shock.","date":"2009","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/19322201","citation_count":142,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31871319","id":"PMC_31871319","title":"Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms.","date":"2019","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/31871319","citation_count":137,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33065002","id":"PMC_33065002","title":"Structures of a Complete Human V-ATPase Reveal Mechanisms of Its Assembly.","date":"2020","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/33065002","citation_count":125,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34857952","id":"PMC_34857952","title":"Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.","date":"2021","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34857952","citation_count":116,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18029348","id":"PMC_18029348","title":"Toward a confocal subcellular atlas of the human proteome.","date":"2007","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/18029348","citation_count":114,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19401719","id":"PMC_19401719","title":"Autosomal recessive cutis laxa syndrome revisited.","date":"2009","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/19401719","citation_count":99,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46082,"output_tokens":1100,"usd":0.077373},"stage2":{"model":"claude-opus-4-6","input_tokens":4322,"output_tokens":1643,"usd":0.094027},"total_usd":0.39356,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":58047,"output_tokens":1945,"usd":0.101658},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":5082,"output_tokens":2197,"usd":0.120502}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2009,\n      \"finding\": \"Loss-of-function mutations in ATP6V0A2 (a2 subunit of the vesicular H+-ATPase) impair vesicular trafficking, leading to distended Golgi cisternae, accumulation of abnormal lysosomes and multivesicular bodies, intracellular retention and aggregation of tropoelastin in the Golgi, reduced extracellular deposition of mature elastin, and increased apoptosis of elastogenic cells. Fibrillin-1 microfibril assembly and secreted lysyl oxidase activity were unaffected, indicating specificity for the Golgi/secretory pathway.\",\n      \"method\": \"siRNA knockdown in human cells, pulse-chase secretion assays, insoluble elastin assays, TUNEL staining, immunostaining, nonsense-mediated decay analysis, patient-derived ARCL2 fibroblasts with DNA sequencing\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (KD, patient cells, pulse-chase, immunostaining) with clear mechanistic readout; replicated in both siRNA and disease-cell contexts\",\n      \"pmids\": [\"19321599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Loss of ATP6V0A2 results in abnormal N- and mucin-type O-glycosylation, consistent with a role of the a2-V-ATPase subunit in maintaining Golgi pH homeostasis required for normal glycosylation.\",\n      \"method\": \"Glycosylation analysis in ARCL2 patient cells and siRNA knockdown cells\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — demonstrated in patient-derived cells and knockdown, consistent across multiple patients\",\n      \"pmids\": [\"19321599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ATP6V0A2 protein localizes to the Golgi apparatus in dermal fibroblasts, and loss of mutated ATP6V0A2 protein delays brefeldin A-induced Golgi collapse, an effect absent in cells deficient for other ARCL-associated proteins (GORAB or PYCR1), suggesting ATP6V0A2 has a specific role in Golgi membrane dynamics/fusion distinct from other ARCL gene products.\",\n      \"method\": \"Immunostaining for subcellular localization; brefeldin A-induced Golgi collapse assay in patient fibroblasts and ATP6V0A2-deficient HeLa cells; comparison with GORAB- and PYCR1-deficient cells\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiment tied to functional consequence, with genetic specificity controls\",\n      \"pmids\": [\"22773132\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Fibroblasts from patients with ATP6V0A2 mutations display elevated TGF-β signalling and increased TGF-β1 levels in supernatant, indicating that ATP6V0A2 loss alters signalling processes beyond glycosylation defects.\",\n      \"method\": \"TGF-β signalling pathway analysis and TGF-β1 ELISA in patient-derived fibroblasts\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single-method biochemical measurement in patient cells, single study\",\n      \"pmids\": [\"22773132\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ATP6V0A2, the a2 subunit of the vacuolar H+-ATPase, localizes to the Golgi apparatus where it is required for proper Golgi acidification, normal N- and O-glycosylation, Golgi membrane dynamics, and vesicular trafficking; loss of function causes tropoelastin aggregation and retention in the Golgi, impaired elastin secretion and extracellular matrix deposition, abnormal lysosome and multivesicular body accumulation, elevated TGF-β signalling, and increased apoptosis of elastogenic cells.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nLooking at the corpus, I need to identify papers actually about ATP6V0A2 (the a2 subunit of the V-type H+ ATPase). Most papers in the retrieved set are about completely different topics (phospholipase A2, annexin A2, HLA-A2, adenosine A2 receptors, etc.) — these are all alias collisions. I will KEEP only papers directly about ATP6V0A2.\n\nKEPT papers:\n- PMID:19321599 — Loss-of-function mutations in ATP6V0A2 (direct mechanistic study)\n- PMID:22773132 — Further characterization of ATP6V0A2-related ARCL (direct mechanistic study)\n- PMID:18157129 — Impaired glycosylation and cutis laxa caused by mutations in ATP6V0A2 (founding paper)\n- PMID:16415858 — V-ATPase interacts with ARNO and Arf6; a2-isoform interaction with ARNO\n- PMID:11836511 — V-ATPases review (general V-ATPase mechanism, relevant context)\n- PMID:32001091 — Structure and Roles of V-type ATPases (structural/mechanistic review)\n- PMID:33065002 — Cryo-EM structures of human V-ATPase\n- PMID:19401719 — Autosomal recessive cutis laxa revisited (ATP6V0A2 mutations)\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"Loss-of-function mutations in ATP6V0A2, encoding the a2 subunit of the V-type H+ ATPase, cause autosomal recessive cutis laxa type II (ARCL2) and wrinkly skin syndrome, and result in abnormal N- and O-glycosylation of serum proteins (CDG-II) and impaired Golgi trafficking in patient fibroblasts, establishing that the a2 subunit has an essential role in Golgi function.\",\n      \"method\": \"Patient mutation sequencing, glycosylation analysis of serum proteins, fibroblast trafficking assays\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (genetics, glycomics, cell biology) in a landmark founding paper, widely replicated\",\n      \"pmids\": [\"18157129\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The a2-isoform of V-ATPase localizes specifically to early endosomes and interacts directly with the Arf GEF ARNO in an intra-endosomal acidification-dependent manner; disruption of this interaction reversibly inhibits endocytosis and blocks protein trafficking between early and late endosomes, identifying the a2 subunit as a pH-sensing scaffold that recruits ARNO/Arf6 to regulate the endocytic degradative pathway.\",\n      \"method\": \"Co-immunoprecipitation, subcellular fractionation, dominant-negative constructs, pharmacological inhibition of V-ATPase acidification, endocytosis assays\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP plus functional rescue and pharmacological dissection in a single rigorous study\",\n      \"pmids\": [\"16415858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Loss of ATP6V0A2 function (by siRNA knockdown or in ARCL2 patient cells) causes distended Golgi cisternae, accumulation of abnormal lysosomes and multivesicular bodies, accumulation of tropoelastin (TE) in the Golgi and in large intracellular/extracellular aggregates, impaired secretion and intracellular retention of TE, reduced extracellular deposition of mature elastin, and increased apoptosis of elastogenic cells; fibrillin-1 assembly and lysyl oxidase activity are unaffected, placing ATP6V0A2 specifically in the vesicular trafficking and TE secretion pathway.\",\n      \"method\": \"siRNA knockdown, pulse-chase secretion assays, insoluble elastin assays, immunostaining, TUNEL apoptosis assay, electron microscopy of Golgi/lysosome ultrastructure, nonsense-mediated decay analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods establishing mechanistic pathway placement, strong phenotypic specificity controls\",\n      \"pmids\": [\"19321599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ATP6V0A2 protein localizes to the Golgi apparatus, is absent or reduced in patient dermal fibroblasts carrying loss-of-function mutations, and its deficiency causes a delay in brefeldin A-induced Golgi collapse not seen in cells deficient for other ARCL-associated proteins (GORAB or PYCR1), indicating a specific role for ATP6V0A2 in Golgi membrane dynamics; patient fibroblasts also show elevated TGF-β signaling and increased secreted TGF-β1, implicating ATP6V0A2 in trafficking/signaling crosstalk.\",\n      \"method\": \"Immunostaining for Golgi localization, Western blot of patient fibroblasts, brefeldin A Golgi collapse assay, TGF-β ELISA and signaling pathway analysis, novel mutation identification by sequencing\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiment with functional consequence, parallel comparator cell lines, multiple orthogonal readouts\",\n      \"pmids\": [\"22773132\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Cryo-EM structures of the human V-ATPase at up to 2.9 Å resolution in three rotational states reveal that the Vo membrane complex contains the a-subunit isoforms (including a2); ATP6AP1 functions as a structural hub connecting multiple Vo subunits and phospholipids in the c-ring, and a luminal glycan coat formed by glycolipids and glycosylated Vo subunits (which include the a2 subunit) is critical for V-ATPase folding, localization, and stability.\",\n      \"method\": \"Cryo-electron microscopy, mass spectrometry-assisted model building, identification of glycolipids and phospholipids\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution cryo-EM structure with MS validation, multiple rotational states\",\n      \"pmids\": [\"33065002\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ATP6V0A2 encodes the a2 subunit of the vesicular H+-ATPase (V-ATPase), which localizes to the Golgi apparatus and early endosomes where it drives organelle acidification; at the Golgi it is required for proper vesicular trafficking, glycoprotein processing (N- and O-glycosylation), and tropoelastin secretion, while at early endosomes it acts as a pH-sensitive scaffold that recruits the Arf GEF ARNO and Arf6 to regulate the endocytic degradative pathway — loss-of-function mutations cause autosomal recessive cutis laxa type II with Golgi fragmentation, impaired elastin secretion, CDG-type glycosylation defects, elevated TGF-β signaling, and increased apoptosis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ATP6V0A2 encodes the a2 subunit of the vacuolar H+-ATPase and localizes to the Golgi apparatus, where it maintains luminal pH homeostasis required for normal N- and O-glycosylation, Golgi membrane dynamics, and vesicular trafficking [PMID:19321599, PMID:22773132]. Loss of ATP6V0A2 causes distended Golgi cisternae, accumulation of abnormal lysosomes and multivesicular bodies, intracellular retention and aggregation of tropoelastin, reduced extracellular elastin deposition, elevated TGF-β signalling, and increased apoptosis of elastogenic cells, while fibrillin-1 assembly and lysyl oxidase activity remain unaffected [PMID:19321599, PMID:22773132]. Loss-of-function mutations in ATP6V0A2 cause autosomal recessive cutis laxa type 2 (ARCL2) [PMID:19321599].\",\n  \"teleology\": [\n    {\n      \"year\": 2009,\n      \"claim\": \"Establishing that ATP6V0A2 is required for Golgi-dependent vesicular trafficking and elastin secretion answered how V-ATPase a2 loss leads to the cutis laxa phenotype: tropoelastin aggregates in the Golgi rather than being secreted, while fibrillin-1 and lysyl oxidase are unaffected, pinpointing a selective secretory pathway defect.\",\n      \"evidence\": \"siRNA knockdown in human cells, pulse-chase secretion assays, insoluble elastin assays, TUNEL staining, immunostaining, and patient-derived ARCL2 fibroblasts\",\n      \"pmids\": [\"19321599\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The mechanism by which Golgi pH elevation selectively traps tropoelastin but not fibrillin-1 is unknown\",\n        \"Whether a2-dependent acidification is required in all cell types or specifically in elastogenic cells is untested\",\n        \"The direct relationship between glycosylation defects and tropoelastin aggregation has not been dissected\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstrating abnormal N- and O-glycosylation upon ATP6V0A2 loss established that the a2 subunit is essential for Golgi pH-dependent glycosylation fidelity, linking V-ATPase dysfunction to a congenital disorder of glycosylation.\",\n      \"evidence\": \"Glycosylation analysis in ARCL2 patient cells and siRNA knockdown cells\",\n      \"pmids\": [\"19321599\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Which specific glycosyltransferases are most sensitive to pH perturbation from a2 loss is undefined\",\n        \"Whether glycosylation defects contribute causally to the elastin secretion defect or represent a parallel consequence is unresolved\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Showing that ATP6V0A2 localizes to the Golgi and that its loss specifically delays brefeldin A-induced Golgi collapse — an effect not seen with loss of other ARCL genes (GORAB, PYCR1) — established a distinct role for the a2 subunit in Golgi membrane fusion dynamics beyond general Golgi dysfunction.\",\n      \"evidence\": \"Immunostaining for localization and brefeldin A Golgi collapse assay in patient fibroblasts and ATP6V0A2-deficient HeLa cells, with genetic specificity controls\",\n      \"pmids\": [\"22773132\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The molecular mechanism by which a2 participates in Golgi membrane fusion or COPI-dependent retrograde trafficking is not defined\",\n        \"Whether the Golgi dynamics defect is a direct consequence of impaired acidification or a pH-independent structural role of a2 is unknown\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Detection of elevated TGF-β signalling and increased secreted TGF-β1 in ATP6V0A2-deficient fibroblasts revealed that a2 loss has signalling consequences beyond glycosylation and secretion, potentially contributing to connective tissue pathology.\",\n      \"evidence\": \"TGF-β signalling pathway analysis and TGF-β1 ELISA in patient-derived fibroblasts\",\n      \"pmids\": [\"22773132\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single-method measurement in one study; independent validation and mechanistic link between Golgi pH and TGF-β activation are lacking\",\n        \"Whether TGF-β elevation is a direct consequence of impaired V-ATPase activity or secondary to ECM disorganization is unresolved\",\n        \"Functional rescue by TGF-β inhibition has not been tested\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown whether ATP6V0A2 contributes to Golgi membrane dynamics through a pH-independent structural role, which specific cargo sorting or glycosylation steps are rate-limited by a2-dependent acidification, and how TGF-β signalling is mechanistically linked to V-ATPase dysfunction.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No reconstitution of a2-containing V-ATPase complexes to separate acidification from structural roles\",\n        \"No in vivo rescue experiments in animal models\",\n        \"Structural basis for a2 incorporation into the V0 sector at the Golgi is uncharacterized\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"complexes\": [\n      \"V-ATPase (V0 sector)\"\n    ],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"ATP6V0A2 encodes the a2 isoform of the V0 sector of the vacuolar H+-ATPase, functioning both as a proton-translocation subunit that drives organelle acidification and as a pH-sensitive scaffold that recruits the Arf GEF ARNO and Arf6 to early endosomes to regulate endocytic trafficking between early and late compartments [PMID:16415858]. At the Golgi apparatus, ATP6V0A2 is required for normal cisternae architecture, vesicular trafficking, N- and O-glycoprotein processing, and tropoelastin secretion; its loss causes Golgi distension, intracellular tropoelastin retention, impaired elastin deposition, elevated TGF-β signaling, and increased apoptosis of elastogenic cells [PMID:19321599, PMID:22773132]. High-resolution cryo-EM structures place the a-subunit within the Vo membrane complex, where a luminal glycan coat formed by glycolipids and glycosylated Vo subunits contributes to V-ATPase folding, localization, and stability [PMID:33065002]. Loss-of-function mutations in ATP6V0A2 cause autosomal recessive cutis laxa type II and wrinkly skin syndrome with congenital disorder of glycosylation type II [PMID:18157129].\",\n  \"teleology\": [\n    {\n      \"year\": 2006,\n      \"claim\": \"Identification of the a2 isoform as a pH-sensitive scaffold on early endosomes resolved how V-ATPase acidification is coupled to vesicular coat recruitment: a2 directly binds the Arf GEF ARNO in an acidification-dependent manner, and disruption of this interaction blocks trafficking from early to late endosomes.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation, dominant-negative constructs, pharmacological V-ATPase inhibition, and endocytosis assays in mammalian cells\",\n      \"pmids\": [\"16415858\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of the pH-dependent a2–ARNO interaction is unknown\",\n        \"Whether a2 scaffolding function is independent of its proton-translocating role has not been dissected\",\n        \"Contribution of other a-subunit isoforms to endosomal ARNO recruitment was not tested\"\n      ]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Human genetics established that a2 is essential for Golgi-based glycoprotein processing: loss-of-function ATP6V0A2 mutations cause ARCL2/wrinkly skin syndrome with CDG-II-type glycosylation defects and impaired Golgi trafficking, linking organelle acidification to a specific Mendelian connective-tissue disorder.\",\n      \"evidence\": \"Patient mutation sequencing, serum glycoprotein analysis (isoelectric focusing), and fibroblast trafficking assays across multiple affected families\",\n      \"pmids\": [\"18157129\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Which specific glycosyltransferase steps are pH-sensitive and disrupted by a2 loss was not determined\",\n        \"Genotype–phenotype correlation across different ATP6V0A2 mutations remained incomplete\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Mechanistic dissection showed that a2 specifically controls tropoelastin secretion and elastin assembly: its loss causes Golgi distension, tropoelastin retention in swollen Golgi cisternae, aberrant lysosomes, reduced extracellular elastin deposition, and increased apoptosis, while fibrillin-1 and lysyl oxidase pathways are unaffected.\",\n      \"evidence\": \"siRNA knockdown and ARCL2 patient fibroblasts analyzed by pulse-chase secretion assays, insoluble elastin quantification, electron microscopy, and TUNEL apoptosis assay\",\n      \"pmids\": [\"19321599\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Why tropoelastin is selectively sensitive to a2 loss while other secreted ECM proteins are not is unexplained\",\n        \"Whether apoptosis is a direct consequence of Golgi dysfunction or secondary to aggregated tropoelastin toxicity is unresolved\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Golgi localization of a2 was directly demonstrated and its role in Golgi membrane dynamics distinguished from other ARCL genes: a2-deficient fibroblasts show delayed brefeldin A-induced Golgi collapse and elevated TGF-β1 secretion, revealing crosstalk between Golgi pH regulation and growth factor signaling.\",\n      \"evidence\": \"Immunostaining, brefeldin A collapse kinetics, TGF-β ELISA, and comparison with GORAB- and PYCR1-deficient fibroblasts\",\n      \"pmids\": [\"22773132\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which a2 loss elevates TGF-β signaling (mis-sorting of TGF-β receptors vs. impaired lysosomal degradation) is unresolved\",\n        \"Whether the Golgi-collapse delay reflects altered membrane fusion or fission was not distinguished\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Cryo-EM structures of the intact human V-ATPase resolved the position of the a-subunit within the Vo membrane sector and revealed that a luminal glycan coat and bound phospholipids are critical for complex assembly, stability, and localization, providing the first atomic-level context for pathogenic ATP6V0A2 mutations.\",\n      \"evidence\": \"Cryo-EM at up to 2.9 Å resolution in three rotational states with mass spectrometry-assisted identification of glycolipids and phospholipids\",\n      \"pmids\": [\"33065002\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No isoform-specific structure of the a2 subunit has been determined\",\n        \"How a2-specific sequences determine Golgi/early-endosome targeting versus other a-isoform targeting is structurally unexplained\",\n        \"Impact of specific ARCL2 missense mutations on Vo assembly and rotation has not been modeled\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include how a2 isoform-specific sequences determine its dual Golgi/early-endosome targeting, whether a2's scaffolding function for ARNO/Arf6 can be separated from its proton-translocation role, and by what mechanism a2 loss selectively impairs tropoelastin secretion and activates TGF-β signaling.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No reconstituted system has tested a2 scaffolding independently of proton pumping\",\n        \"Tissue-specific compensation by other a-subunit isoforms is poorly understood\",\n        \"Structural basis for selective tropoelastin retention in a2-null Golgi is unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1, 4]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [0, 2, 3]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [0, 1, 2, 3]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 1, 4]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 2]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"complexes\": [\n      \"V-ATPase (V0 sector)\"\n    ],\n    \"partners\": [\n      \"ARNO\",\n      \"ARF6\",\n      \"ATP6AP1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}